Read more on our new COVID-19 programme.
Imagine a world where doctors are able to target and remove pathogens, such as harmful cells, bacteria, toxins, and inflammatory cytokines, directly from a patient’s bloodstream. The ability to precisely extract unwanted disease causing substances in this way would revolutionise the treatment of deadly blood-borne diseases, benefiting patients and clinicians around the world. That is MediSieve’s vision for the future of healthcare, and it can be achieved through the process of magnetic blood filtration.
MediSieve plans to use a combination of different magnetic beads to target the various pathogens and cytokines that lead to the symptoms of Sepsis.
The device rapidly reduces the parasitaemia of severe Malaria patients who have been hospitalised and prescribed IV drug treatment.
MediSieve's device captures Leukaemia blasts from the bloodstream in order to reduce the patient's white blood cell count.
The MediSieve System purifies blood by targeting harmful substances with magnetic beads
Virtual, 1-5th February 2021
LIfe Science Nation
Virtual, 17-19th November 2020
MediSieve Ltd, a biotech company which has developed an innovative blood filtration device, today a...
Job Title: Quality Manager
Reports to: Head of Engineering and Quality
Start Date: ...